comparemela.com
Home
Live Updates
Incytes Opzelura slapped with vitiligo delay amid topical JAKs eczema launch : comparemela.com
Incyte's Opzelura slapped with vitiligo delay amid topical JAK's eczema launch
As Incyte Corporation’s recently-minted Opzelura gets off to the races in eczema, the drug has run up against a setback in another dermatology indication.
Related Keywords
,
Incyte
,
Opzelura
,
Jakafi
,
Jak Inhibitors
,
Topical Drug Delivery
,
Eczema
,
Atopic Dermatitis
,
Nda Application Process
,
Fierce Pharma Homepage
,
Pharma
,
comparemela.com © 2020. All Rights Reserved.